- ►shouxi.net S Grinspoon, A Carr - New England Journal of Medicine, 2005 - content.nejm.org From the Program in Nutritional Metabo- lism and the Neuroendocrine Unit, Mas-
sachusetts General Hospital and Harvard Medical School, Boston (SG); and the
HIV, Immunology, and Infectious Diseases Clin- ical Services Unit, St. ... Cited by 435 - Related articles - All 7 versions
- ►hivtri.com [PDF] M Schambelan, CA Benson, A Carr, JS Currier … - JAIDS Journal of Acquired Immune Deficiency …, 2002 - journals.lww.com Objective: Alterations in glucose and lipid metabolism, lactic acidemia, bone
disorders, and abnormal body fat distribution have been recognized recently as
frequent complications associated with HIV-1 infection and potent ... Cited by 288 - Related articles - All 24 versions
- ►mapleleafmedical.com [PDF] JP Bastard, M Caron, H Vidal, V Jan, M … - The Lancet, 2002 - Elsevier Patients' fat contained a higher proportion of small adipocytes than control
fat, together with lower mRNA concentrations of the adipogenic differentiation
factors CCAAT-enhancer binding protein (C/EBP) β and α, peroxisome ... Cited by 275 - Related articles - BL Direct - All 7 versions
- ►mapleleafmedical.com [PDF] A Carr, C Workman, DE Smith, J Hoy, J … - Jama, 2002 - Am Med Assoc Context Peripheral lipoatrophy may complicate antiretroviral therapy of human
immunodeficiency virus (HIV) infection, often related to duration and type of
nucleoside analog therapy, and may have a mitochondrial pathogenesis. No ... Cited by 268 - Related articles - BL Direct - All 5 versions
- ►mapleleafmedical.com [PDF] A Carr, C Workman, D Carey, G Rogers, A … - The Lancet, 2004 - Elsevier Limb fat increased by 0·14 kg in the rosiglitazone group and 0·18 kg in the
placebo group (mean difference –0·04 kg [95%CI –0·29 to 0·21]; p=0·74 by
t test), with three participants (one on rosiglitazone and two controls), ... Cited by 236 - Related articles - All 8 versions
MA Noor, T Seneviratne, FT Aweeka, JC Lo, … - Aids, 2002 - journals.lww.com From the From the Department of a Medicine, University of California, the b
Metabolism and Endocrine Sections, San Francisco Department of Veterans Affairs
Medical Center, the Department of c Pharmacology University of California, ... Cited by 224 - Related articles - BL Direct - All 8 versions
A Carr - The Lancet, 2003 - Elsevier In a case-control study, 1081 consecutive, HIV-infected, adult outpatients (261
[15%] women) without active AIDS were recruited from 32 sites worldwide. We
classed patients with at least one moderate or severe subjective ... Cited by 213 - Related articles - All 5 versions
PWG Mallon, J Miller, DA Cooper, A Carr - Aids, 2003 - journals.lww.com Objective: Little prospective data are published on the natural history of
HIV-asso- ciated lipodystrophy (HIVLD) in individuals beginning their first
antiretroviral regimen. To investigate this a study was designed to explore ... Cited by 201 - Related articles - BL Direct - All 6 versions
J Sutinen, AM Hakkinen, J Westerbacka, A … - Antiviral Therapy, 2003 - mapleleafmedical.com Highly active antiretroviral therapy (HAART) is associated with metabolic
adverse events such as insulin resistance and lipodystrophy, that is, atrophy of
subcutaneous fat and accumulation of intra-abdominal fat. Currently, there ... Cited by 189 - Related articles - View as HTML - BL Direct - All 8 versions
- ►hivtri.com [PDF] A Carr - Aids, 2003 - journals.lww.com HIV lipodystrophy is a heterogeneous syndrome, which has yet to be objectively
defined, comprising peripheral lipoatrophy, central fat accumulation and
lipomata, along with hyperlipidaemia, insulin resistance and lactic ... Cited by 182 - Related articles - BL Direct - All 11 versions
